Sexual Health

Erectile dysfunction (ED) is most commonly caused by vascular conditions that reduce blood flow to the penis, including hypertension, atherosclerosis, and type 2 diabetes. Hormonal imbalances such as low testosterone, as well as neurological conditions, medications (particularly antihypertensives and antidepressants), and psychological factors like anxiety and depression, are also significant contributors. Because ED frequently signals underlying cardiovascular disease, a new diagnosis warrants a thorough medical evaluation rather than isolated treatment of the symptom.

Testosterone plays a primary role in regulating libido, and men with clinically low testosterone (hypogonadism, generally defined as total testosterone below 300 ng/dL) commonly report reduced sexual desire and difficulties with arousal. The relationship between testosterone and erectile function is more nuanced, as erections depend heavily on vascular and neurological health; testosterone replacement improves libido more reliably than it improves erectile rigidity. Symptoms of low testosterone overlap with many other conditions, so diagnosis should be based on repeated morning serum measurements combined with clinical evaluation.

Yes, robust evidence indicates that aerobic exercise, weight loss, a Mediterranean-style diet, smoking cessation, and reduced alcohol intake can meaningfully improve erectile function, particularly in men whose ED is linked to cardiovascular risk factors or metabolic syndrome. Studies have shown that moderate-intensity aerobic exercise performed at least 40 minutes per session, four times per week, produces clinically significant improvements in erectile function scores. These lifestyle interventions work largely by improving endothelial function and blood flow, addressing the same pathways targeted by phosphodiesterase-5 inhibitors.

Premature ejaculation (PE) is defined clinically as ejaculation that consistently occurs within approximately one minute of penetration, causing personal distress, and it is the most common male sexual dysfunction affecting an estimated 20–30% of men. First-line pharmacological treatments include daily or on-demand selective serotonin reuptake inhibitors (SSRIs), particularly dapoxetine where approved, and topical anesthetic agents that reduce penile sensitivity. Behavioral techniques such as the stop-start and squeeze methods have demonstrated efficacy, and combination therapy using both pharmacological and behavioral approaches tends to produce the most durable outcomes.

Research on this topic is ongoing and methodologically complex, but some studies report associations between high-frequency pornography use and reduced sexual satisfaction, lower arousal with a partner, and self-reported erectile difficulties in the absence of organic disease, often termed "porn-induced erectile dysfunction." However, the causal direction is debated, and current evidence is largely observational and reliant on self-report, making it difficult to distinguish pornography use as a cause versus a consequence of pre-existing sexual dissatisfaction. Psychological frameworks such as conditioning and attentional bias are the proposed mechanisms, but controlled clinical trials are limited.

Testosterone secretion is strongly tied to sleep, with the majority of daily testosterone release occurring during slow-wave and REM sleep stages; studies restricting healthy young men to five hours of sleep per night for one week observed a 10–15% reduction in daytime testosterone levels. Obstructive sleep apnea (OSA) is independently associated with low testosterone, erectile dysfunction, and reduced libido, and treatment with continuous positive airway pressure (CPAP) has been shown to improve sexual function in men with OSA. Chronic sleep insufficiency also elevates cortisol, which suppresses testosterone production through hypothalamic-pituitary-gonadal axis inhibition.

The most prevalent sexually transmitted infections (STIs) in men include human papillomavirus (HPV), chlamydia, gonorrhea, genital herpes (HSV-2), and syphilis, with HPV being the most common overall. Consistent and correct condom use significantly reduces transmission risk for most STIs, though it provides incomplete protection against infections spread by skin-to-skin contact such as herpes and HPV. Vaccination against HPV is recommended for males up to age 26 and can be considered up to age 45 after clinical discussion, and pre-exposure prophylaxis (PrEP) is highly effective at preventing HIV in high-risk individuals.